Person:
Posch, Christian

Profile Picture

Email Address

AA Acceptance Date

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

Posch

First Name

Christian

Name

Posch, Christian

Filters

20161

Settings

Author's Publications: search.filters.isAuthorOfPublication.2a28e3a0-a832-4063-824b-d9d860a6a525

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Publication
    Acyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells
    (Impact Journals LLC, 2016) Vujic, Igor; Sanlorenzo, Martina; Esteve-Puig, Rosaura; Vujic, Marin; Kwong, Andrew; Tsumura, Aaron; Murphy, Ryan; Moy, Adrian; Posch, Christian; Monshi, Babak; Rappersberger, Klemens; Ortiz-Urda, Susana
    Oncogenic NRAS mutations are frequent in melanoma and lead to increased downstream signaling and uncontrolled cell proliferation. Since the direct inhibition of NRAS is not possible yet, modulators of NRAS posttranslational modifications have become an area of interest. Specifically, interfering with NRAS posttranslational palmitoylation/depalmitoylation cycle could disturb proper NRAS localization, and therefore decrease cell proliferation and downstream signaling. Here, we investigate the expression and function of NRAS depalmitoylating acyl protein thioesterases 1 and 2 (APT-1, APT-2) in a panel of NRAS mutant melanoma cells. First, we show that all melanoma cell lines examined express APT-1 and APT-2. Next, we show that siRNA mediated APT-1 and APT-2 knock down and that the specific APT-1 and -2 inhibitors ML348 and ML349 have no biologically significant effects in NRAS mutant melanoma cells. Finally, we test the dual APT-1 and APT-2 inhibitor palmostatin B and conclude that palmostatin B has effects on NRAS downstream signaling and cell viability in NRAS mutant melanoma cells, offering an interesting starting point for future studies.